Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blankenstein, Thomas Prof. Dr. (2) Conrad, Thomas Dr. (1) Haas, Simon Dr. rer. nat. (1) Keller, Ulrich Dr. med. (3) Mathas, Stephan Dr. (1) Na, Il-Kang Dr. (69) Obermayer-Wasserscheid, Benedikt Dr. (3) Pezzutto, Antonio Prof. Dr. (1) Strzelecka, Paulina Maria (1) Walther, Wolfgang Prof. Dr. (1) (-) Janz, Martin Dr. (1) (-) Schmitt, Clemens Prof. Dr. (3) 2019 (1) 2021 (1) 2022 (1) Advanced Light Microscopy (1) AG Schreiber [ECRC] (1) Animal Phenotyping (1) Bioinformatics and Omics Data Science (4) Biology of Malignant Lymphomas (58) Cancer Genetics and Cellular Stress Responses (89) Developmental Neurobiology (1) Electron Microscopy (1) Genetics and Genomics of Cardiovascular Diseases (1) Genome Diversification & Integrity (1) Genomics (1) (-) Immune Dysregulations in Oncology (3) Immune Regulation and Cancer (5) Mathematical Modelling of Cellular Processes (1) Mechanism-based Cancer Therapies (6) Microenvironmental Regulation in Autoimmunity and Cancer (2) Molecular Biology of Peptide Hormones (23) Molecular Immunology and Gene Therapy (1) Molecular Physiology of Somatic Sensation (1) Protein Production and Characterization (2) Proteomics (5) Proteomics and Metabolomics (1) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (2) Translational Bioinformatics (1) Translational Oncology of Solid Tumors (19) Translational Tumorimmunology (2) Tumor heterogeneity and treatment resistance in pediatric cancer (7) 3 Results: Active Filter: Janz, Martin Dr.Schmitt, Clemens Prof. Dr.Immune Dysregulations in Oncology Sort: Result score Newest to oldest Oldest to newest August 01, 2021 / Leuk Lymphoma Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient A. Bittner J. Radke D. Eurich E. Wiener S. Denker I. Anagnostopoulos I.K. Na F.L. Heppner L. Bullinger C.A. Schmitt January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt December 19, 2019 / Int J Hematol Oncol A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response S. Denker A. Bittner I.K. Na J. Kase M. Frick I. Anagnostopoulos M. Hummel C.A. Schmitt
August 01, 2021 / Leuk Lymphoma Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient A. Bittner J. Radke D. Eurich E. Wiener S. Denker I. Anagnostopoulos I.K. Na F.L. Heppner L. Bullinger C.A. Schmitt
January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt
December 19, 2019 / Int J Hematol Oncol A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response S. Denker A. Bittner I.K. Na J. Kase M. Frick I. Anagnostopoulos M. Hummel C.A. Schmitt